Prolonging remission with rituximab maintenance therapy

被引：18

作者：

Hainsworth, JD ^{[1
]}

机构：

[1] Sarah Cannon Canc Ctr, Nashville, TN 37203 USA

来源：

SEMINARS IN ONCOLOGY | 2004年 / 31卷 / 01期

关键词：

D O I：

10.1053/j.seminoncol.2003.12.005

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：17 / 21

页数：5

共 11 条

[1] Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden:: clinical and molecular evaluation [J].

Colombat, P ;

Salles, G ;

Brousse, N ;

Eftekhari, P ;

Soubeyran, P ;

Delwail, V ;

Deconinck, E ;

Haïoun, C ;

Foussard, C ;

Sebban, C ;

Stamatoullas, A ;

Milpied, N ;

Boué, F ;

Taillan, B ;

Lederlin, P ;

Najman, A ;

Thièblemont, C ;

Montestruc, F ;

Mathieu-Boué, A ;

Benzohra, A ;

Solal-Céligny, P .

BLOOD, 2001, 97 (01) :101-106

[2]

Czuczman MS, 2001, BLOOD, V98, p601A

[3] Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy [J].

Czuczman, MS ;

Grillo-López, AJ ;

White, CA ;

Saleh, M ;

Gordon, L ;

LoBuglio, AF ;

Jonas, C ;

Klippenstein, D ;

Dallaire, B ;

Varns, C .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) :268-276

[4] Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma:: Safety and efficacy of re-treatment [J].

Davis, TA ;

Grillo-López, AJ ;

White, CA ;

McLaughlin, P ;

Czuczman, MS ;

Link, BK ;

Maloney, DG ;

Weaver, RL ;

Rosenberg, J ;

Levy, R .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (17) :3135-3143

[5]

Ghielmini M, 2002, BLOOD, V100, p161A

[6] Single-agent rituximab as first-line and maintenance treatment for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma: A phase II trial of the Minnie Pearl Cancer Research Network [J].

Hainsworth, JD ;

Litchy, S ;

Barton, JH ;

Houston, GA ;

Hermann, RC ;

Bradof, JE ;

Greco, FA .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (09) :1746-1751

[7]

Hainsworth JD, 2003, BLOOD, V102, p411A

[8] Rituximab as first-line and maintenance therapy for patients with indolent non-Hodgkin's lymphoma [J].

Hainsworth, JD ;

Litchy, S ;

Burris, HA ;

Scullin, DC ;

Corso, SW ;

Yardley, DA ;

Morrissey, L ;

Greco, FA .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (20) :4261-4267

[9] Rituximab plus chemotherapy in follicular and mantle cell lymphomas [J].

Hiddemann, W ;

Dreyling, M ;

Unterhalt, M .

SEMINARS IN ONCOLOGY, 2003, 30 (01) :16-20

[10]

MCLAUGHLIN P, 2003, P AN M AM SOC CLIN, V22, P564

← 1 2 →